日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)

I期精原细胞瘤睾丸癌监测中的影像学检查方式和频率:一项随机、III期、非劣效性试验(TRISST)的结果

Joffe, Johnathan K; Cafferty, Fay H; Murphy, Laura; Rustin, Gordon J S; Sohaib, Syed A; Gabe, Rhian; Stenning, Sally P; James, Elizabeth; Noor, Dipa; Wade, Simona; Schiavone, Francesca; Swift, Sarah; Dunwoodie, Elaine; Hall, Marcia; Sharma, Anand; Braybrooke, Jeremy; Shamash, Jonathan; Logue, John; Taylor, Henry H; Hennig, Ivo; White, Jeff; Rudman, Sarah; Worlding, Jane; Bloomfield, David; Faust, Guy; Glen, Hilary; Jones, Rachel; Seckl, Michael; MacDonald, Graham; Sreenivasan, Thiagarajan; Kumar, Satish; Protheroe, Andrew; Venkitaraman, Ramachandran; Mazhar, Danish; Coyle, Victoria; Highley, Martin; Geldart, Tom; Laing, Robert; Kaplan, Richard S; Huddart, Robert A

AB006. Effectiveness of chemotherapy as the first-line treatment for thymic tumors with pleural dissemination

AB006. 化疗作为胸膜播散性胸腺肿瘤一线治疗的疗效

Cunningham, David; Stenning, Sally P; Smyth, Elizabeth C; Okines, Alicia F; Allum, William H; Rowley, Sam; Stevenson, Laura; Grabsch, Heike I; Alderson, Derek; Crosby, Thomas; Griffin, S Michael; Mansoor, Wasat; Coxon, Fareeda Y; Falk, Stephen J; Darby, Suzanne; Sumpter, Kate A; Blazeby, Jane M; Langley, Ruth E; Zhang, Xuefei; Gao, Lanting; Hao, Xiuxiu; Yu, Fenghao; Gu, Zhitao; Fang, Wentao

Dynamic methods for ongoing assessment of site-level risk in risk-based monitoring of clinical trials: A scoping review

临床试验风险监测中,持续评估试验中心层面风险的动态方法:范围界定综述

Cragg, William J; Hurley, Caroline; Yorke-Edwards, Victoria; Stenning, Sally P

Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604)

强化诱导化疗(卡铂、博来霉素、长春新碱和顺铂/博来霉素、依托泊苷和顺铂)与标准博来霉素、依托泊苷和顺铂治疗预后不良的生殖细胞肿瘤的长期疗效:一项随机 II 期试验 (ISRCTN53643604)

Cafferty, Fay H; White, Jeff D; Shamash, Jonathan; Hennig, Ivo; Stenning, Sally P; Huddart, Robert A

Triggered or routine site monitoring visits for randomised controlled trials: results of TEMPER, a prospective, matched-pair study

随机对照试验的触发式或常规现场监查访视:TEMPER 前瞻性配对研究的结果

Stenning, Sally P; Cragg, William J; Joffe, Nicola; Diaz-Montana, Carlos; Choudhury, Rahela; Sydes, Matthew R; Meredith, Sarah

Defining a New Prognostic Index for Stage I Nonseminomatous Germ Cell Tumors Using CXCL12 Expression and Proportion of Embryonal Carcinoma.

利用 CXCL12 表达和胚胎癌比例定义 I 期非精原细胞瘤性生殖细胞肿瘤的新预后指数

Gilbert Duncan C, Al-Saadi Reem, Thway Khin, Chandler Ian, Berney Daniel, Gabe Rhian, Stenning Sally P, Sweet Joan, Huddart Robert, Shipley Janet M

Biopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma: results from the UK MRC OE02 trial

活检肿瘤比例可预测可切除食管癌的病理肿瘤反应和化疗获益:英国医学研究委员会OE02试验结果

Hale, Matthew D; Nankivell, Matthew; Hutchins, Gordon G; Stenning, Sally P; Langley, Ruth E; Mueller, Wolfram; West, Nicholas P; Wright, Alexander I; Treanor, Darren; Hewitt, Lindsay C; Allum, William H; Cunningham, David; Hayden, Jeremy D; Grabsch, Heike I

Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration

儿童和青少年颅外生殖细胞肿瘤:合作之路

Olson, Thomas A; Murray, Matthew J; Rodriguez-Galindo, Carlos; Nicholson, James C; Billmire, Deborah F; Krailo, Mark D; Dang, Ha M; Amatruda, James F; Thornton, Claire M; Arul, G Suren; Stoneham, Sara J; Pashankar, Farzana; Stark, Daniel; Shaikh, Furqan; Gershenson, David M; Covens, Allan; Hurteau, Jean; Stenning, Sally P; Feldman, Darren R; Grimison, Peter S; Huddart, Robert A; Sweeney, Christopher; Powles, Thomas; Lopes, Luiz Fernando; dos Santos Agular, Simone; Chinnaswamy, Girish; Khaleel, Sahar; Abouelnaga, Sherif; Hale, Juliet P; Frazier, A Lindsay

A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604)

一项针对预后不良的生殖细胞肿瘤的强化诱导化疗(CBOP/BEP)与标准BEP的随机2期试验(MRC TE23、CRUK 05/014、ISRCTN 53643604)

Huddart, Robert A; Gabe, Rhian; Cafferty, Fay H; Pollock, Philip; White, Jeff D; Shamash, Jonathan; Cullen, Michael H; Stenning, Sally P